Lester et al v. American Home Products Corporation et al
| Polly Lester and Jimmy Lester |
| Warner Chilcott (US), LLC, American College of Obstetricians and Gynecologists, Barr Laboratories, Inc., Designwrite, LLC, Wyeth, Inc., Wyeth-Ayerst Pharmaceuticals, Inc., Saatchi & Saatchi Healthcare Communications, Inc., Pharmacia & Upjohn Company, Inc., Bristol-Myers Squibb Company, Wyeth Laboratories, Inc., Dannemiller Memorial Educational Foundation, Inc., Pfizer Inc., Wyeth Pharmaceuticals, Inc., Ketchum, Inc., American Home Products Corporation, Designwrite, Inc., Wyeth-Ayerst International, Inc., ESI Lederle Inc., Rite Aid of WV, Inc., Solvay Pharmaceuticals, Inc., Solvay America, Inc., Wyeth Pharmaceuticals, Greenstone LLC, National Committee for Quality Assurance, American College of Physicians and Klemptner Advertising, Inc. |
| 3:2008cv00576 |
| May 27, 2008 |
| U.S. District Court for the Southern District of West Virginia |
| Personal Inj. Prod. Liability Office |
| Mason |
| Robert C Chambers |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 24, 2008. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 28 CONFIRMATION from Eastern District of Arkansas that the case has been opened in that district as 4:08-03879, filed 10/24/2008. (gan) |
| Transmitted case to Eastern District of Arkansas via extract civil case feature of CM/ECF (jkk) |
| Filing 27 TRANSFER ORDER from the Judicial Panel on Multidistrict Litigation entered 10/09/08: Pursuant to 28 USC 1407, this action is transferred to the Eastern District of Arkansas and is assigned to the Honorable William R. Wilson, Jr., for inclusion in the coordinated or consolidated pretrial proceedings occurring in MDL No. 1507, In Re: Prempro Products Liability Litigation. CASE CLOSED. (cc: attys; any unrepresented party) (jkk) |
Filing 26
MANAGEMENT ORDER upon hearing held 06/16/08; the first filed case, Doerfler v. American Home Products, 3:08-0346, is designated as the lead case for the hormone replacement cases, Civil Action No. 3:08-0346 through 3:08-0787 inclusive; the remainder of the cases are stayed; the Court will allow a party to apply to the Court to lift the stay on an individual case if that party demonstrates some particularized reason why the stay should be lifted; each visiting attorney associated with a defendant shall file a Statement of Visiting Attorney in the lead case and shall pay a fee of $50 for case numbers 3:08-0346; 3:08-0434, 3:08-0522 and 3:08-0610 for a total of $250; pursuant to LR 83.6(e), the Court waives the visiting attorney fees for the remainder of the individual actions; any Defendant who has not filed its disclosures pursuant to Rule 7.1 of the Federal Rules of Civil Procedure shall file its disclosures only in the lead case; Plaintiffs to file their motion to remand, with supporting memorandum, in the lead case only on or before June 26, 2008; Defendants to file their response on or before July 14, 2008; Plaintiffs to file their reply on or before July 27, 2008. Signed by Judge Robert C. Chambers on 6/17/2008. (cc: attys; any unrepresented party) (cdb)
|
| Filing 25 INITIAL MANAGEMENT CONFERENCE held by Judge Robert C. Chambers with counsel on 6/16/2008. No court reporter present. Proceeding not recorded. (cdb) |
| Filing 24 COPY OF LETTER on behalf of Pfizer, Inc., Pharmacia & Upjohn LLC and Greenstone Ltd. (the Upjohn Defendants) to Jeffrey Luthi, Clerk of the Judicial Panel on Multidistrict Litigation, notifying the Clerk of the Panel of potential tag-along actions and requesting that tag-along procedures be utilized in transferring these actions to MDL No. 1507, pending in the USDC for the Eastern District of Arkansas. (cdb) |
| Filing 23 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Wyeth, Inc., Wyeth-Ayerst International, Inc., Wyeth Pharmaceuticals, Wyeth Pharmaceuticals, Inc. (skh) |
| Filing 22 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Klemptner Advertising, Inc., Saatchi & Saatchi Healthcare Communications, Inc. (skh) |
| Filing 21 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Ketchum, Inc. (skh) |
| Filing 20 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Designwrite, Inc., Designwrite, LLC. (skh) |
| Filing 19 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Rite Aid of WV, Inc. (skh) |
| Filing 18 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Warner Chilcott (US), LLC. (skh) |
| Filing 17 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Warner Chilcott (US), LLC. (skh) |
| Filing 16 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants Wyeth, Inc., Wyeth-Ayerst International, Inc., Wyeth Pharmaceuticals, Inc. (skh) |
| Filing 15 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Barr Laboratories, Inc. (skh) |
| Filing 14 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Solvay Pharmaceuticals, Inc., Solvay America, Inc. (skh) |
| Filing 13 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Wyeth (incorrectly sued as Wyeth, Inc.), Wyeth Pharmaceuticals, Wyeth Pharmaceuticals, Inc., Wyeth-Ayerst International, Inc. (incorrectly sued as Wyeth Ayerst International Inc.) (skh) |
| Filing 12 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Klemptner Advertising, Inc., Saatchi & Saatchi Healthcare Communications, Inc. (skh) |
| Filing 11 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Ketchum, Inc. (skh) |
| Filing 10 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Designwrite, Inc., Designwrite, LLC. (skh) |
| Filing 9 ANSWER TO #5 AMENDED COMPLAINT with Jury Demand by Rite Aid of WV, Inc. (skh) |
| Filing 8 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Barr Laboratories, Inc. (skh) |
| Filing 7 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Bristol-Myers Squibb Company. (skh) |
| Filing 6 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Bristol-Myers Squibb Company. (skh) |
| Filing 5 AMENDED COMPLAINT by plaintiffs amending the complaint attached to #1 Notice of Removal against all defendants. (skh) |
| Filing 4 DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants Greenstone LLC, Pharmacia & Upjohn Company, Inc., Pfizer Inc. (skh) |
| Filing 3 ANSWER TO COMPLAINT ATTACHED TO #1 NOTICE OF REMOVAL with Jury Demand by Greenstone LLC, Pharmacia & Upjohn Company, Inc., Pfizer Inc. (skh) |
| Filing 2 PROOF OF NOTICE by Greenstone LLC, Pharmacia & Upjohn Company, Inc., Pfizer Inc., with Notice to State Court of Filing of Notice of Removal attached as Exhibit 1. (skh) |
| Filing 1 NOTICE OF REMOVAL by Pfizer Inc., Pharmacia & Upjohn Company LLC (incorrectly sued as Pharmacia & Upjohn Company, Inc., d/b/a Pharmacia & Upjohn, Inc.) and Greenstone Ltd. (incorrectly sued as Greenstone LLC d/b/a Greenstone Ltd.) with complaint and docket sheet from Circuit Court of Mason County and other miscellaneous documents. Filing Fee $350.00. Receipt #22250. (Attachments: #1 Exhibit 1 (complaint), #2 Exhibit 2 (Judge Chambers order in 5:05-0094), #3 Exhibit 3 (Board of Pharmacy letter of 8/23/2000), #4 Exhibit (4) (Judge Faber order in 1:01-0553), #5 Exhibit 5 (State Court docket sheet), #6 Exhibit 6 (Consents to Removal), #7 Civil Cover Sheet) (skh) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
